135 related articles for article (PubMed ID: 16387680)
21. In vitro anticomplementary activity of constituents from Morinda morindoides.
Cimanga K; De Bruyne T; Lasure A; Van Poel B; Pieters L; Vanden Berghe D; Vlietinck A; Kambu K; Tona L
J Nat Prod; 1995 Mar; 58(3):372-8. PubMed ID: 7775983
[TBL] [Abstract][Full Text] [Related]
22. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
Gancevici G; Popescu C; Toporan M
Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
[No Abstract] [Full Text] [Related]
23. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
[TBL] [Abstract][Full Text] [Related]
24. Inhibition effects of isolated compounds from Artemisia rubripes Nakai of the classical pathway on the complement system.
Jung S; Lee JH; Lee YC; Moon HI
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):244-6. PubMed ID: 21854097
[TBL] [Abstract][Full Text] [Related]
25. Anisakis simplex: the activity of larval products on the complement system.
García-Hernández P; Rodero M; Cuéllar C
Exp Parasitol; 2007 Jan; 115(1):1-8. PubMed ID: 16777096
[TBL] [Abstract][Full Text] [Related]
26. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
Pillay NS; Kellaway LA; Kotwal GJ
Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
[TBL] [Abstract][Full Text] [Related]
27. [Effect of medicinal preparations on the complement: inhibition of subcomponent C1q binding to a target].
Bichucher AM; Kozlov LV
Eksp Klin Farmakol; 2007; 70(6):25-8. PubMed ID: 18318191
[TBL] [Abstract][Full Text] [Related]
28. Effect of the extract of the tamarind (Tamarindus indica) fruit on the complement system: studies in vitro and in hamsters submitted to a cholesterol-enriched diet.
Landi Librandi AP; Chrysóstomo TN; Azzolini AE; Recchia CG; Uyemura SA; de Assis-Pandochi AI
Food Chem Toxicol; 2007 Aug; 45(8):1487-95. PubMed ID: 17383788
[TBL] [Abstract][Full Text] [Related]
29. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
Blom AM; Nandakumar KS; Holmdahl R
Ann Rheum Dis; 2009 Jan; 68(1):136-42. PubMed ID: 18276745
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacological modulation of complement system: proposition of anticomplement therapy].
Yamauchi Y
Nihon Rinsho; 1981 Apr; 39(4):1791-800. PubMed ID: 7031292
[No Abstract] [Full Text] [Related]
31. Complement-inhibiting and anti-inflammatory properties of chlorazole fast pink 2BL.
Doherty NS
Clin Exp Immunol; 1981 Feb; 43(2):260-9. PubMed ID: 7273480
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory activity of Jatropha multifida latex on classical complement pathway activity in human serum mediated by a calcium-binding proanthocyanidin.
Kosasi S; Hart LA; van Dijk H; Labadie RP
J Ethnopharmacol; 1989 Nov; 27(1-2):81-9. PubMed ID: 2615430
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates.
Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A
Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882
[TBL] [Abstract][Full Text] [Related]
34. Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175.
Miyamoto Y; Hirose H; Matsuda H; Nakano S; Ohtani M; Kaneko M; Nishigaki K; Nomura F; Kitamura H; Kawashima Y
Trans Am Soc Artif Intern Organs; 1985; 31():508-11. PubMed ID: 3837498
[No Abstract] [Full Text] [Related]
35. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
36. Complement activation and protein adsorption by carbon nanotubes.
Salvador-Morales C; Flahaut E; Sim E; Sloan J; Green ML; Sim RB
Mol Immunol; 2006 Feb; 43(3):193-201. PubMed ID: 16199256
[TBL] [Abstract][Full Text] [Related]
37. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.
Ling M; Piddlesden SJ; Morgan BP
Clin Exp Immunol; 1995 Dec; 102(3):582-8. PubMed ID: 8536376
[TBL] [Abstract][Full Text] [Related]
38. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
Hui KM; Magnadóttir B; Schifferli JA; Inal JM
Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
[TBL] [Abstract][Full Text] [Related]
39. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the activity of polyanions and polycations on the classical and alternative pathways of complement.
Weiler JM; Linhardt RJ
Immunopharmacology; 1989; 17(2):65-72. PubMed ID: 2722479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
